Abpro (ABP) Stock Price, News & Analysis

Company Overview

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

Key Stats

• Today's Range: $0.23 to $0.26
• 50-Day Range: $0.16 to $0.32
• 52-Week Range: $0.15 to $13.00
• Volume: 7.87 million shs
• Average Volume: 4.26 million shs
• Market Capitalization: $19.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Buy

Abpro Stock Analysis - MarketRank™

Abpro scored higher than 72% of companies evaluated by MarketBeat, and ranked 303rd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Abpro has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Abpro has a consensus price target of $4.00, representing about 1,583.5% upside from its current price of $0.24.

Amount of Analyst Coverage

Abpro has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: N/A
• Proj. Earnings Growth: N/A

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.19% of the float of Abpro has been sold short.

Short Interest Ratio / Days to Cover

Abpro has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Abpro does not currently pay a dividend.

Dividend Growth

Abpro does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.19% of the float of Abpro has been sold short.

Short Interest Ratio / Days to Cover

Abpro has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 2.6 / 5
• News Sentiment: N/A

News Sentiment

Abpro has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Abpro this week, compared to 0 articles on an average week.

Search Interest

11 people have searched for ABP on MarketBeat in the last 30 days. This is an increase of 22% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Abpro to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Abpro insiders have bought more of their company's stock than they have sold. Specifically, they have bought $20,170.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

13.70% of the stock of Abpro is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 23.30% of the stock of Abpro is held by institutions.

ABP Stock Analysis - Frequently Asked Questions

How have ABP shares performed this year?

Abpro's stock was trading at $1.79 at the beginning of the year. Since then, ABP stock has decreased by 86.7% and is now trading at $0.2376.

How were Abpro's earnings last quarter?

Abpro Holdings Inc. (NASDAQ:ABP) posted its quarterly earnings data on Wednesday, August, 13th. The company reported ($0.04) EPS for the quarter.

When did Abpro IPO?

Abpro (ABP) raised $60 million in an initial public offering on Friday, May 11th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Nomura and Oppenheimer were co-managers.

Who are Abpro's major shareholders?

Abpro's top institutional shareholders include Geode Capital Management LLC (0.32%).
View institutional ownership trends.

How do I buy shares of Abpro?

Shares of ABP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/13/2025
• Today: 9/23/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ABP
• CIK: 1893219
• Web: www.atlanticcoastalacquisition.com
• Phone: 248-890-7200
• Fax: N/A
• Employees: 15
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Abpro: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +1,583.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.23 million
• Net Margins: N/A
• Pretax Margin: -6,720.77%
• Return on Equity: N/A
• Return on Assets: -241.16%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.15
• Quick Ratio: 0.15

Sales & Book Value

• Annual Sales: $180 thousand
• Price / Sales: 105.82
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.29) per share
• Price / Book: -0.82

Miscellaneous

• Outstanding Shares: 80,170,000
• Free Float: 69,184,000
• Market Cap: $19.05 million
• Optionable: N/A
• Beta: 0.03